EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieLeserbrief

Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial

Tai-Ming Hsu, Hui Wen Chang, Ai-Lin Chen, James Cheng-Chung Wei iD

International Journal of Rheumatic Diseases · 2024

DOI: 10.1111/1756-185x.15024 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift International Journal of Rheumatic Diseases, 2024. Verfasst von Tai-Ming Hsu und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, Chung Shan Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Gout, Hyperuricemia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 8 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The authors confirm that the data supporting the findings of this study are available within the article.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GoutHyperuricemiaHumansGout SuppressantsUric AcidDouble-Blind Method

Substanzen

Gout SuppressantsUric Acid

Autor:innen und Institutionen

  • School of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • School of Medical Science and Technology, Chung Shan Medical University, Taichung, Taiwan.
  • Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.
  • Department of Allergy, Immunology, and Rheumatology, Chung Shan Medical University Hospital, Taichung, Taiwan.
  • Graduate Institute of Integrated Medicine, China Medical University, Taichung, Taiwan.

ORCID-Profile: James Cheng-Chung Wei

Zitieren

APA

Hsu, T. M., Chang, H. W., Chen, A. L., & Wei, J. C. (2024). Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial. International Journal of Rheumatic Diseases. https://doi.org/10.1111/1756-185x.15024

Vancouver

Hsu TM, Chang HW, Chen AL, Wei JC. Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial. International Journal of Rheumatic Diseases. 2024. doi:10.1111/1756-185x.15024

BibTeX
@article{Hsu2024,
  author = {Hsu, Tai-Ming and Chang, Hui Wen and Chen, Ai-Lin and Wei, James Cheng-Chung},
  title = {Comment on serum urate‐lowering efficacy and safety of Tigulixostat in gout patients with hyperuricemia: A randomized, double‐blind, placebo‐controlled, dose‐finding trial},
  journal = {International Journal of Rheumatic Diseases},
  year = {2024},
  doi = {10.1111/1756-185x.15024}
}
Kostenlos starten →